Immunome
IMNM
#4888
Rank
S$2.38 B
Marketcap
S$20.24
Share price
-5.54%
Change (1 day)
-16.36%
Change (1 year)

Market capitalization of Immunome (IMNM)

Market cap: S$2.38 Billion

As of November 2026 Immunome has a market cap of S$2.38 Billion. This makes Immunome the world's 4888th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Immunome from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.38 B-22.29%
2025S$3.07 B243.92%
2024S$0.89 B48.09%
2023S$0.60 B1580.38%
2022S$35.93 M-83.05%
2021S$0.21 B57.05%
2020S$0.13 B

End of Day market cap according to different sources

On Nov 21st, 2026 the market cap of Immunome was reported to be:

S$2.38 Billion
by Nasdaq info icon info icon
S$2.38 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
S$0.98 B-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA